Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

Wednesday’s Trading Day
1.06 -0.04 / -3.64%
As of May 04
Day’s Change
Thursday’s Pre-Market   Switch to standard view »
0.75 -0.31 / -29.25%
 
Volume: --

Today’s Trading

Previous close1.10
Today’s open1.12
Day’s range1.01 - 1.18
Volume7,532,120
Average volume (3 months)1,569,383
Market cap$70.3M
Dividend yield--
Data as of 05/04/2016

Growth & Valuation

Earnings growth (last year)-198.92%
Earnings growth (this year)+46.40%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+44.44%
P/E ratioNM
Price/Sales0.89
Price/Book2.03

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...+0.14+4.79%
JNPJuniper Pharmaceutic...+0.81+12.50%
NVLSNivalis Therapeutics...-0.04-0.89%
CATBCatabasis Pharmaceut...-0.22-4.91%
Data as of 05/04/2016

Financials

Last reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$175.9M
Annual profit (last year)-$148.3M
Net profit margin-84.34%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

Partner Offers

Search for Jobs